Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-14
1996-04-09
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
055062342
ABSTRACT:
.beta.-carbolines of formula I are described ##STR1## in which R.sup.A is a C.sub.6-12 aryl hetaryl as defined herein, that can be substituted singly to multiply with halogen, C.sub.1-4 -alkoxy, C.sub.1-4 -alkyl or amino,
REFERENCES:
patent: 4435403 (1984-03-01), Braestrup et al.
patent: 4596808 (1986-06-01), Braestrup et al.
patent: 4623649 (1986-11-01), Huth et al.
patent: 4644062 (1987-02-01), Haffer et al.
patent: 4645773 (1987-02-01), Engelstoft et al.
patent: 4731365 (1988-03-01), Biere et al.
patent: 4757070 (1988-07-01), Biere et al.
patent: 4877792 (1989-10-01), Biere et al.
patent: 4933345 (1990-06-01), Huth et al.
patent: 4960777 (1990-10-01), Biere et al.
patent: 5145847 (1992-09-01), Bohlmann et al.
Neef et al., Heterocycles 20(7), 1983. pp. 1295-1313.
Huth Andreas
Rahtz Dieter
Schmiechen Ralph
Schneider Herbert
Seidelmann Dieter
Henley III Raymond
Schering Aktiengesellschaft
Spivack Phyllis G.
LandOfFree
.beta.-carboline derivatives for use as pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-carboline derivatives for use as pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-carboline derivatives for use as pharmaceutical agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139224